Aclarion, Inc. (NASDAQ:ACONW) Sees Significant Decrease in Short Interest

Aclarion, Inc. (NASDAQ:ACONW) was the recipient of a large decline in short interest in April. As of April 30th, there was short interest totaling 100 shares, a decline of 65.8% from the April 15th total of 292 shares. Based on an average trading volume of 7,518 shares, the short-interest ratio is presently 0.0 days.

Aclarion Stock Performance

NASDAQ ACONW opened at $0.03 on Thursday. The stock’s 50 day moving average price is $0.04 and its two-hundred day moving average price is $0.04. Aclarion has a 52 week low of $0.02 and a 52 week high of $0.23.

Aclarion Company Profile

Aclarion, Inc, a healthcare technology company, leverages for Magnetic Resonance Spectroscopy (MRS) in the United States. It develops NOCISCAN Post-Processor suite of software applications comprising NOCICALC that receives the raw un-processed NOCISCAN MRS exam data and post-processes that raw data into final spectra and performs various degenerative pain biomarker; and NOCIGRAM, a clinical decision support software. The company was formerly known as Nocimed, Inc and changed its name to Aclarion, Inc in December 2021.